Some reviews describe a broad range of experimental findings, but there remains a gap between promising research and established, FDA-approved clinical use
A patient with gut symptoms may need evaluation for inflammatory bowel disease, infection, celiac disease, medication effects, food reactions, or other causes
GHK-Cu is a copper-binding tripeptide with potent antioxidant, anti-inflammatory, and regenerative properties, shown to reduce amyloid plaques, enhance cognition, and support tissue remodeling through TGF1 modulation
5-Amino-1 MQ Capsules 50mg 5-Amino-1MQ is a small molecule that inhibits NNMT (nicotinamide N-methyltransferase), an enzyme involved in cellular energy metabolism
However, the largest Phase IIb trial involving 536 subjects failed to demonstrate statistically significant weight loss compared to placebo at the primary 12-week endpoint, leading Metabolic Pharmaceuticals to terminate development in 2007